BRISTOL MYERS SQUIBB CO (BMY)

About BRISTOL MYERS SQUIBB CO

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Opdualag for the treatment of unresectable or metastatic melanoma; and Camzyos to treat symptomatic obstructive HCM. It also offers Zeposia to treat relapsing forms of multiple sclerosis; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Krazati for the treatment of KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); and Cobenfy to treat schizophrenia. In addition, it offers Eliquis for a reduction in risk of stroke/systemic embolism and for the treatment of DVT/PE; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; Pomalyst/Imnovid for multiple myeloma; Sprycel for Philadelphia chromosome-positive chronic myeloid leukemia; and Abraxane for the treatment of breast cancer. Further, it provides Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; and NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, specialty pharmacies, retailers, hospitals, clinics, and government agencies. Bristol-Myers Squibb Company has a strategic collaboration with Arcus Biosciences, Inc. to develop a novel treatment regimen that delivers tumor control in kidney cancer. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in Princeton, New Jersey.

Headquarters: Princeton, NJ · Employees: 32500 · Website: https://www.bms.com

Supply-chain relationships for BMY

• SHOULDER INNOVATIONS, INC. (SI) — partner
• BioNTech SE (BNTX) — partner
• JOHNSON & JOHNSON (JNJ) — partner
• PFIZER INC (PFE) — supplier
• BIO-TECHNE Corp (TECH) — supplier
• 10x Genomics, Inc. (TXG) — supplier
• Accenture plc (ACN) — supplier
• ARVINAS, INC. (ARVN) — partner
• Stevanato Group S.p.A. (STVN) — supplier
• Evotec SE (EVO.DE) — partner
• DANAHER CORP /DE/ (DHR) — supplier
• Catalent, Inc. (CTLT) — supplier
• 2seventy bio, Inc. (TSVT) — partner
• MICROSOFT CORP (MSFT) — supplier
• Ono Pharmaceutical Co., Ltd. (4528.T) — partner
• ICON PLC (ICLR) — supplier
• Lonza Group AG (LONN.SW) — supplier
• Samsung Biologics Co., Ltd. (207940.KS) — supplier
• Guardant Health, Inc. (GH) — supplier
• MCKESSON CORP (MCK) — supplier
• WEST PHARMACEUTICAL SERVICES INC (WST) — supplier
• CARDINAL HEALTH INC (CAH) — supplier
• VEEVA SYSTEMS INC (VEEV) — supplier
• IQVIA HOLDINGS INC. (IQV) — supplier
• THERMO FISHER SCIENTIFIC INC. (TMO) — supplier
• Cencora, Inc. (COR) — supplier
• PFIZER INC (PFE) — partner

Frequently asked questions about BRISTOL MYERS SQUIBB CO (BMY)

What is BRISTOL MYERS SQUIBB CO (BMY)?

BRISTOL MYERS SQUIBB CO (BMY) is a publicly traded company in the Pharmaceutical Preparations sector (Drug Manufacturers - General), listed on NYSE. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Who are BRISTOL MYERS SQUIBB CO's key suppliers and customers?

Macroplane tracks BRISTOL MYERS SQUIBB CO's (BMY) supply chain. Key suppliers include PFIZER INC (PFE), BIO-TECHNE Corp (TECH), 10x Genomics, Inc. (TXG), Accenture plc (ACN), Stevanato Group S.p.A. (STVN), DANAHER CORP /DE/ (DHR), Catalent, Inc. (CTLT), MICROSOFT CORP (MSFT), and 11 more.